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Background: Hearing loss is the most common birth defect and the most prevalent sensorineural disorder in
developed countries. More than 50% of prelingual deafness is genetic, most often autosomal recessive and
nonsyndromic, of which 50% can be attributed to the disorder DFNB1, caused by mutations in GJB2 and GJB6.
Sensorineural hearing loss and male infertility (Deafness-Infertility Syndrome; DIS) is a contiguous gene deletion
syndrome resulting from homozygous deletion of the CATSPER2 and STRC genes on chromosome 15q15.3. Females
with DIS have only hearing loss and are fertile. Until recently this syndrome has only been described in three
consanguineous families and 2 nonconsanguineous families.
Results: We recently indentified a patient with hearing loss and macrocephaly who was found to be homozygous
for this deletion. Her nonconsanguineous parents are both carriers. We examined our database of patients tested
by array CGH and determined that just over 1% of our patients are heterozygous for this deletion. If this number is
representative of the general population, this implies a 1% carrier frequency and prevalence of DIS of 1 in 40,000
individuals.
Conclusion: We propose that DIS is a greatly under-diagnosed cause of deafness and should be considered in
children with hearing loss. Likewise, current molecular genetic testing panels for hearing loss in the United States
should be expanded to include deletion/duplication analysis of this region.
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Hearing loss is the most common birth defect and the
most prevalent sensorineural disorder in developed
countries. One out of every 500 newborns has perman-
ent bilateral sensorineural hearing loss ≥40 dB; by ado-
lescence, the prevalence increases to 3.5 per 1000 [1].
More than 50% of prelingual deafness is genetic, most
often autosomal recessive and nonsyndromic, while only
a small percentage of prelingual deafness is syndromic
or autosomal dominant nonsyndromic. Approximately
50% of autosomal recessive nonsyndromic hearing loss* Correspondence: hoppmanchaney.nicole@mayo.edu
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reproduction in any medium, provided the orcan be attributed to the disorder DFNB1, caused by mu-
tations in GJB2 (which encodes the protein connexin 26)
and GJB6 (which encodes the protein connexin 30) [2].
The carrier rate in the general population for a recessive
deafness-causing GJB2 mutation is approximately one
in 33 [2].
Sensorineural hearing loss and male infertility (Deafness-
Infertility Syndrome; DIS) is a contiguous gene deletion
syndrome resulting from homozygous deletion of the
CATSPER2 (responsible for male infertility) and STRC (re-
sponsible for hearing loss) genes on chromosome 15q15.3.
Females with DIS have only hearing loss and are fertile [3].
Until recently, this syndrome had only been described
in three consanguineous families [4] and two individuals
with unrelated parents [5-7]. However, a patient withtral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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macrocephaly presented to the Medical Genetics de-
partment at Mayo Clinic recently and was found to be
homozygous for this deletion, resulting in DIS. Both
were found to be carriers. We then decided to retro-
spectively examine our database of patients tested by
array CGH in order to determine the frequency of this
deletion in our patient population.
Results
The proband is a 13-month-old girl who presented to
the Medical Genetics Department for evaluation regard-
ing congenital hearing loss. Her past medical history
was unremarkable. She was the second child born to a
35-year-old mother. Except for morning nausea the
pregnancy was not complicated. The mother did not
take any medications during gestation. Delivery was at
term (40 weeks), birth weight was 3856 grams (75th
centile), and no perinatal complications were reported.
Her psychomotor development has been normal. The
patient was crawling at age 7 months, standing up at
age 8 months, and walked unassisted at age 10 months.
Her language at age 13 months was appropriately lim-
ited to babbling and a few words.
At age 13 months, her physical examination was nor-
mal except for the presence of macrocephaly. Her height
was 75 cm (70th centile), and her weight was 12.5 kg
(94th centile). Her head circumference was 49.7 cm
(>99th centile). In addition to macrocephaly, anterior
fontanel was still open (2–2 cm) and there was mild bra-
chycephaly, but the face was non-dysmorphic. A review
of her growth chart revealed that she had normal head
circumference at birth (35 cm, 56th centile), but her
head size exceeded the 99th centile at age 4 months.Figure 1 Phenotypic features of the proband, demonstrating macroce
in the 500–6000 Hz range (B).Since that time, her head circumference has consistently
tracked above the 99th centile (Figure 1A). The patient
does not have a history of seizures or any other neuro-
logical deficits, and there is also no family history of
macrocephaly.
With regard to the patient’s hearing loss, she failed the
initial newborn hearing screen in both ears. Follow-up
diagnostic testing via high- frequency tympanometry,
otoacoustic emissions (both transient & distortion prod-
uct), and auditory brainstem response (ABR) suggested
normal middle ear function, good 8th nerve synchrony,
but a mild hearing loss at least for the 2000–4000 Hz
range in both ears. The hearing loss was most likely
sensorineural in nature given the normal middle ear
function (evidenced by tympanometry) with absent
otoacoustic emissions. Behavioral audiological testing via
visual reinforcement audiometry in the sound-field was
first completed at 8 months of age and has continued at
6 months intervals. Behavioral testing verified the hear-
ing loss predicted by ABR and has suggested some pro-
gression to date. The patient’s most recent test results
suggested a mild sloping to moderate hearing loss (most
likely sensorineural in type) involving the 500–6000 Hz
range for at least the better ear but involving both ears
(Figure 1B). Family history is negative for early onset of
hearing loss, and her parents are not consanguineous.
In the context of mild macrocephaly, delayed closure of
fontanelles and underlying hearing loss, we considered a
number of diagnostic possibilities including peroxisomal
disorders, mannosidosis, organic acidemias and chromo-
somal alterations. The initial diagnostic workup included
urinalysis and plasma peroxisomal panel, which were
normal except for marginal elevation of phytanic acid.
Sequencing of GJB2 and deletion/duplication testing ofphaly from age 4 months on (A) and mild-moderate hearing loss
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omic hybridization (array CGH) detected an approximately
62 kilobase homozygous deletion at 15q15.3 (human
genome build hg18 coordinates 41,676,219-41,738,593,
Figure 2A). The deleted interval contains the entire STRC
and CATSPER2 genes, as well as a portion of CKMT1B
(Figure 2B). Parental array CGH testing demonstrated that
both parents are carriers of a heterozygous deletion at
15q15.3 (Figure 2C).
Because of the paucity of previously reported patients in
the literature, along with the fact that three were reportedlyA
B
C htomdnaborp
Figure 2 Array CGH results demonstrating a homozygous deletion on
CATSPER2 genes as well as a portion of CKMT1B as shown by the red
this deletion (C).from consanguineous unions, we decided to examine the
frequency of this deletion in our database of patient sam-
ples. In 2011, our laboratory tested 5,152 patient samples
(peripheral blood specimens) by array CGH. Of those, 57
patients were found to be heterozygous for similar dele-
tions including the STRC and CATSPER2 genes, two of
whom were siblings, indicating that 1.09% of patients are
carriers. If this figure is representative of the general popu-
lation, this would indicate that approximately 1 in 40,000
individuals is born with a homozygous deletion of this re-
gion, resulting in deafness and, in males, infertility.rehtafre
15q15.3 in the proband (A) that includes the full STRC and
rectangle (B). Both parents were found to be heterozygous carriers of
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We present here the third reported case of a patient
with DIS whose parents were not consanguineous
(Table 1). In this particular situation, because the patient
presented with macrocephaly in addition to hearing loss,
an array CGH was ordered, which is how the homozy-
gous deletion of 15q15.3 was detected. However, in the
absence of any other phenotypic findings, array CGH is
typically not performed in children with isolated hearing
loss. This means that females with 15q15.3 homozygous
deletion, who have only deafness, would not have an
array CGH ordered. Males with DIS have infertility in
addition to hearing loss; however these individuals are
most likely evaluated during childhood (before the infer-
tility phenotype would be apparent) and therefore do
not routinely have array CGH performed for diagnostic
purposes. Currently, array CGH is the only clinical test
available that can detect deletions resulting in DIS in the
United States. Given the presence of a heterozygous de-
letion of this region in just over 1% of our patient popu-
lation (hence polymorphic), we hypothesize that DIS is
an under-diagnosed cause of hearing loss.
One important limitation to point out is that our study
cohort is comprised of individuals referred to clinics for
a variety of reasons, including but not limited to devel-
opmental delay, dysmorphism, congenital anomalies, etc.
Because our cohort does not represent a “normal” popu-
lation, we cannot rule out the possibility that hetero-
zygosity for this deletion is enriched in our patient
population for a different reason, such as predisposing
to phenotypic abnormalities. However, this is unlikely
given the fact that heterozygous individuals are asymp-
tomatic and that homozygous individuals have only
hearing loss and, in males, infertility, as the only clinical
manifestations. We also cannot rule out the possibility
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Abbreviations: HL Hearing Loss, MR Mental Retardation, HC Head Circumference.however such mutations are likely not as common as
deletions [8], and array CGH testing is not typically
performed on patients with hearing loss as a sole pheno-
typic finding. In addition, a recent publication reported a
carrier frequency of 1.6%; however the cohort analyzed
in this study was significantly smaller (n = 729) and com-
bined multiple data sets [7]. Another recent publication
reported a higher than expected incidence of homozy-
gous deletion of the 15q15.3 region in a handful of indi-
viduals with hearing loss who were negative for GJB2
mutation [8]. Taken together with our data set (n > 5000),
we propose that DIS is a greatly under-diagnosed cause
of hearing loss and should be included in the differential
diagnosis for all individuals with hearing loss. There-
fore, current molecular genetic panels testing for muta-
tions that cause hearing loss should be expanded to
include deletion/duplication analysis for this region of
chromosome 15. Targeted mutation analysis, such as
multiplex ligation-dependent probe amplification, could
also be considered in the case of a targeted or tiered ap-
proach to genetic testing for hearing loss.
Methods
Genomic DNA extraction for molecular cytogenetic
studies was performed using the PureGene method
(Qiagen Inc., Valencia, CA) on peripheral blood lym-
phocytes. DNA was resuspended in 1X Tris-EDTA (TE,
pH 8.0) and the concentration was measured with a
Nanodrop ND-100 Spectrophotometer (Thermo Fisher
Scientific Inc., Wilmington, DE). To perform array
CGH, 1 μg of patient genomic DNA was labeled with
Cy5 and an equal amount of gender-matched control
DNA was labeled with Cy3 using the Genomic DNA
Labeling Kit (Agilent Technologies Inc., Santa Clara,
CA) according to the manufacturer’s protocol. Each
sample was purified using a Multiscreen PCR 96-wellmicrodeletion
Phenotype Consanguinity?
orineural HL and no syndromic features; one male
m motility assessed: asthenoteratozoospermia
Yes
sorineural HL and no syndromic features; sperm
motility assessment not performed
Yes
rineural HL and no syndromic features; both males
have asthenoteratozoospermia
Yes
surineural HL, infertility (asthenoteratozoospermia) No; two brothers
with similar
phenotype
, bilateral sensorineural HL, MR, short stature,
atures, normal HC, sperm motility assessment not
performed
No
erate bilateral sensorineural HL, macrocephaly No
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tient and control DNA were mixed along with Cot-1 DNA
and 2X hybe buffer (Agilent Technologies Inc., Santa
Clara, CA). The mixtures were denatured at 95°C for 3
minutes and then incubated at 37°C for 30 minutes. Each
mixture was then applied to an Agilent 4 × 180 K oligo-
nucleotide array CGH slide and incubated while rotating
at 65°C for 24 hours. Slides were washed and scanned on
a G2565CA Microarray Scanner System (Agilent Tech-
nologies Inc., Santa Clara, CA). Data was analyzed using
DNA Analytics version 4.0 (Agilent Technologies Inc.,
Santa Clara, CA). This research was approved by the
Mayo Clinic Institutional Review Board (IRB).
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